Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2012-02-24 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes 'initiated a share buyback program' on January 20, 2012, referencing the relevant European Commission Regulation. A share buyback program is a transaction where a company purchases its own shares from the open market. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document length is very short (251 chars), but it describes the initiation of the action rather than just announcing the publication of a report, making POS a more specific fit than RPA or RNS.
2012-02-24 English
Regulatory Filings 2012
Regulatory Filings Classification · 99% confidence The document text is very short (225 characters) and explicitly mentions the initiation of a share buyback program ('aktietilbagekøbsprogram') in accordance with EU regulation 2273/2003 ('Safe Harbour'). It concludes with 'Læs hele meddelelsen' (Read the full announcement), indicating this is a brief notification about a corporate action rather than the detailed regulatory filing itself. The action described is a transaction in own shares (share repurchase). Therefore, the most appropriate classification is Transaction in Own Shares (POS).
2012-02-24 Danish
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document is a formal announcement dated February 24, 2012, detailing a specific transaction made by a company executive (Peder Holk Nielsen, Koncerndirektør) involving the exercise of options (purchase of shares) for Novozymes B-shares. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing. The Danish text explicitly mentions compliance with the Securities Trading Act (Værdipapirhandelslovens paragraf 28a) regarding the disclosure of such transactions. This matches the 'Director's Dealing' category (DIRS). The document length is short (1762 chars), but it is a primary disclosure, not an announcement of another report.
2012-02-24 English
Director's Dealing 2012
Director's Dealing Classification · 100% confidence The document text is extremely short (219 characters) and explicitly reports transactions under a specific section of the Danish Securities Trading Act, referencing ISIN and a stock symbol. This structure strongly suggests a mandatory disclosure of insider or related-party transactions, which aligns with the 'Director's Dealing' category (DIRS). Although it mentions 'Read the whole announcement,' implying a link to a fuller report, the content itself is the core transaction disclosure, making DIRS more specific than a general RPA or RNS. Given the context of reporting transactions by individuals associated with the company, DIRS is the most appropriate classification.
2012-02-24 English
Director's Dealing 2012
Director's Dealing Classification · 100% confidence The document text is extremely short (219 characters) and explicitly reports transactions under a specific section of the Danish Securities Trading Act, referencing ISIN and a stock symbol. This structure strongly suggests a mandatory disclosure of insider or related-party transactions, which aligns with the 'Director's Dealing' category (DIRS). Although it mentions 'Read the whole announcement,' implying a link to a fuller report, the content itself is the core transaction disclosure, making DIRS more specific than a general RPA or RNS. Given the context of reporting transactions by individuals associated with the company, DIRS is the most appropriate classification.
2012-02-23 English
Director's Dealing 2012
Director's Dealing Classification · 99% confidence The document is dated February 23, 2012, and explicitly states it is a disclosure required under the Danish Securities Trading Act ('Værdipapirhandelslovens paragraf 28a'). The content is a table detailing a transaction (Salg af aktier - Sale of shares) conducted by a 'Koncerndirektør' (Executive Director/CSO) named Per Falholt. This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing. The code for this is DIRS.
2012-02-23 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.